{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:41:11Z","timestamp":1778845271455,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","award":["Bourse McLaughlin du doyen de la Facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 Laval"],"award-info":[{"award-number":["Bourse McLaughlin du doyen de la Facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 Laval"]}],"id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","award":["TEVA Innovation Canada fellowship grants"],"award-info":[{"award-number":["TEVA Innovation Canada fellowship grants"]}],"id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00428-017-2290-0","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T19:28:20Z","timestamp":1519154900000},"page":"469-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors"],"prefix":"10.1007","volume":"472","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-8053","authenticated-orcid":false,"given":"Emilie","family":"Perron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Neub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Dominique","family":"Tartar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"de la Fouchardiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"issue":"5","key":"2290_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaad.2012.10.041","volume":"68","author":"LL Chen","year":"2013","unstructured":"Chen LL, Jaimes N, Barker CA, Busam KJ, Marghoob AA (2013) Desmoplastic melanoma: a review. J Am Acad Dermatol 68(5):825\u2013833. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2012.10.041","journal-title":"J Am Acad Dermatol"},{"key":"2290_CR2","doi-asserted-by":"crossref","unstructured":"Carlson JA, Dickersin GR, Sober AJ, Barnhill RL (1995) Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 28 cases. Cancer 75(2):478\u2013494","DOI":"10.1002\/1097-0142(19950115)75:2<478::AID-CNCR2820750211>3.0.CO;2-O"},{"issue":"1","key":"2290_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian BC (2014) The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 9(1):239\u2013271. \n                    https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104658","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2290_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/106689690401200103","volume":"12","author":"PA Kay","year":"2004","unstructured":"Kay PA, Pinheiro AD, Lohse CM, Pankratz VS, Olesen K, Lewis JE, Nascimento A (2004) Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases. Int J Surg Pathol 12(1):17\u201324. \n                    https:\/\/doi.org\/10.1177\/106689690401200103","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"2290_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/gcc.20310","volume":"45","author":"V Muthusamy","year":"2006","unstructured":"Muthusamy V, Hobbs C, Nogueira C, Cordon-Cardo C, McKee PH, Chin L, Bosenberg MW (2006) Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer 45(5):447\u2013454. \n                    https:\/\/doi.org\/10.1002\/gcc.20310","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"2290_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ng.3382","volume":"47","author":"AH Shain","year":"2015","unstructured":"Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian BC (2015) Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet 47(10):1194\u20131199. \n                    https:\/\/doi.org\/10.1038\/ng.3382","journal-title":"Nat Genet"},{"issue":"7653","key":"2290_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Sabarinathan R, Mularoni L, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, de Paoli-Iseppi R, Vilain RE, Shang P, Lau LMS, Dagg RA, Schramm SJ, Pritchard A, Dutton-Regester K, Newell F, Fitzgerald A, Shang CA, Grimmond SM, Pickett HA, Yang JY, Stretch JR, Behren A, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RPM, L\u00f3pez-Bigas N, Pearson JV, Thompson JF, Scolyer RA, Mann GJ (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545(7653):175\u2013180. \n                    https:\/\/doi.org\/10.1038\/nature22071","journal-title":"Nature"},{"issue":"1","key":"2290_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI23237","volume":"115","author":"R Ciampi","year":"2005","unstructured":"Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115(1):94\u2013101. \n                    https:\/\/doi.org\/10.1172\/JCI23237","journal-title":"J Clin Invest"},{"issue":"6","key":"2290_CR9","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/sj.jid.5700725","volume":"127","author":"B Dessars","year":"2007","unstructured":"Dessars B, De Raeve LE, El HH, Debouck CJ, Sidon PJ, Morandini R et al (2007) Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. J Invest Dermatol 127(6):1468\u20131470. \n                    https:\/\/doi.org\/10.1038\/sj.jid.5700725","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2290_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/pcmr.12148","volume":"26","author":"T Botton","year":"2013","unstructured":"Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC (2013) Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res 26(6):845\u2013851. \n                    https:\/\/doi.org\/10.1111\/pcmr.12148","journal-title":"Pigment Cell Melanoma Res"},{"key":"2290_CR11","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/ncomms4116","volume":"5","author":"T Wiesner","year":"2014","unstructured":"Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I et al (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116","journal-title":"Nat Commun"},{"issue":"4","key":"2290_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/PAS.0000000000000761","volume":"41","author":"SM Amin","year":"2017","unstructured":"Amin SM, Haugh AM, Lee CY, Zhang B, Bubley JA, Merkel EA, Verz\u00ec AE, Gerami P (2017) A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms. Am J Surg Pathol 41(4):491\u2013498. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000761","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2290_CR13","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1038\/srep11200","volume":"5","author":"S Lee","year":"2015","unstructured":"Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A (2015) TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms. Sci Rep 5(1):11200. \n                    https:\/\/doi.org\/10.1038\/srep11200","journal-title":"Sci Rep"},{"issue":"3","key":"2290_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAS.0000000000000769","volume":"41","author":"KJ Busam","year":"2017","unstructured":"Busam KJ, Shah KN, Gerami P, Sitzman T, Jungbluth AA, Kinsler V (2017) Reduced H3K27me3 expression is common in nodular melanomas of childhood associated with congenital melanocytic nevi but not in proliferative nodules. Am J Surg Pathol 41(3):396\u2013404. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000769","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"2290_CR15","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1038\/onc.2016.486","volume":"36","author":"HS Kim","year":"2017","unstructured":"Kim HS, Jung M, Kang HN, Kim H, Park CW, Kim SM, Shin SJ, Kim SH, Kim SG, Kim EK, Yun MR, Zheng Z, Chung KY, Greenbowe J, Ali SM, Kim TM, Cho BC (2017) Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK\/PI3K inhibition or MEK\/CDK4\/6 inhibition. Oncogene 36(23):3334\u20133345. \n                    https:\/\/doi.org\/10.1038\/onc.2016.486","journal-title":"Oncogene"},{"issue":"1","key":"2290_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/pcmr.12560","volume":"30","author":"J Turner","year":"2017","unstructured":"Turner J, Couts K, Sheren J, Saichaemchan S, Ariyawutyakorn W, Avolio I, Cabral E, Glogowska M, Amato C, Robinson S, Hintzsche J, Applegate A, Seelenfreund E, Gonzalez R, Wells K, Bagby S, Tentler J, Tan AC, Wisell J, Varella-Garcia M, Robinson W (2017) Kinase gene fusions in defined subsets of melanoma. Pigment Cell Melanoma Res 30(1):53\u201362. \n                    https:\/\/doi.org\/10.1111\/pcmr.12560","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7","key":"2290_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm.2166","volume":"16","author":"N Palanisamy","year":"2010","unstructured":"Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, Han B, Cao Q, Cao X, Suleman K, Kumar-Sinha C, Dhanasekaran SM, Chen Y, Esgueva R, Banerjee S, LaFargue CJ, Siddiqui J, Demichelis F, Moeller P, Bismar TA, Kuefer R, Fullen DR, Johnson TM, Greenson JK, Giordano TJ, Tan P, Tomlins SA, Varambally S, Rubin MA, Maher CA, Chinnaiyan AM (2010) Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 16(7):793\u2013798. \n                    https:\/\/doi.org\/10.1038\/nm.2166","journal-title":"Nat Med"},{"issue":"4","key":"2290_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.29825","volume":"138","author":"JS Ross","year":"2016","unstructured":"Ross JS, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J, Yelensky R, Lipson D, Ali SM, Elvin JA, Vergilio JA, Roels S, Miller VA, Nakamura BN, Gray A, Wong MK, Stephens PJ (2016) The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 138(4):881\u2013890. \n                    https:\/\/doi.org\/10.1002\/ijc.29825","journal-title":"Int J Cancer"},{"issue":"5","key":"2290_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/pcmr.12388","volume":"28","author":"AM Menzies","year":"2015","unstructured":"Menzies AM, Yeh I, Botton T, Bastian BC, Scolyer RA, Long GV (2015) Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell Melanoma Res 28(5):607\u2013610. \n                    https:\/\/doi.org\/10.1111\/pcmr.12388","journal-title":"Pigment Cell Melanoma Res"},{"issue":"24","key":"2290_CR20","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","volume":"19","author":"KE Hutchinson","year":"2013","unstructured":"Hutchinson KE, Lipson D, Stephens PJ, Otto G, Lehmann BD, Lyle PL, Vnencak-Jones CL, Ross JS, Pietenpol JA, Sosman JA, Puzanov I, Miller VA, Pao W (2013) BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition. Clin Cancer Res 19(24):6696\u20136702. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1746","journal-title":"Clin Cancer Res"},{"key":"2290_CR21","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C (2014) The landscape of kinase fusions in cancer. Nat Commun 5:4846. \n                    https:\/\/doi.org\/10.1038\/ncomms5846","journal-title":"Nat Commun"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2290-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T20:18:20Z","timestamp":1550693900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2290-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2290-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"28 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the Declaration of Helsinki and has been approved by the research ethics committee of the Centre L\u00e9on B\u00e9rard (Ref: L17-70).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}